In the present study, we identify and validate a significant decrease in focal adhesion signaling following treatment with BMS754807 and dasatinib and go on to show that FAK inhibition is sufficient to inhibit HNSCC cell growth in 2D and 3D systems and patient ex vivo cultures. The gene discussed is PTK2; the disease is head and neck squamous cell carcinoma.